Correction to “Longitudinal studies of blood‐based biomarkers for dementia in primary care: A systematic review and meta‐analysis”

by Clinical Neuropsychologist Online | Saturday, September 12, 2026 | Dementia

Alzheimer’s &Dementia, Volume 22, Issue 9, September 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 12, 2026 Neuro-Dementia...

Implementing Dementia-Friendly Videos in Everyday Care: A Qualitative Study of Frontline Staff Experiences

by Clinical Neuropsychologist Online | Friday, September 11, 2026 | Dementia

Dementia, Ahead of Print. Dementia-friendly videos are adapted audiovisual resources designed to support care for people living with moderate to severe dementia. Although evidence suggests these videos can enhance comfort, engagement, and communication, little is...

ENT1 inhibition links oligodendrocyte lipid metabolism to connectivity in tauopathy

by Clinical Neuropsychologist Online | Friday, September 11, 2026 | Dementia

Abstract INTRODUCTION Metabolic dysfunction, altered adenosine signaling, and white matter abnormalities are implicated in tauopathies, but their relationship to network disconnection remains unclear. Myelinating oligodendrocytes may represent a metabolically...

Mapping Namaste Care Training for Staff in Long-Term Care Settings: A Scoping Review

by Clinical Neuropsychologist Online | Friday, September 11, 2026 | Dementia

Dementia, Ahead of Print. Namaste Care is a person-centered intervention for people with dementia in long-term care, particularly those in advanced stages. However, evidence on how staff are trained and supported to deliver Namaste Care remains fragmented. This...

Dynamic frailty exposure and cognitive aging trajectories: A multicohort study

by Clinical Neuropsychologist Online | Friday, September 11, 2026 | Dementia

Abstract INTRODUCTION The cognitive implications of longitudinal frailty exposure remain unclear. We examined associations of baseline frailty status, two-wave frailty change, and mean frailty burden with annual cognitive change and cognitive aging trajectories....

TMEM106B is a selective modulator of TDP‐43 pathology in Alzheimer’s disease

by Clinical Neuropsychologist Online | Thursday, September 10, 2026 | Dementia

Abstract INTRODUCTION Co-pathologies – including Lewy body, vascular, and TDP-43 lesions – are common in Alzheimer’s disease (AD), contributing to its clinical and pathological heterogeneity. Genetic risk factors may drive mixed pathology presentation, but their...